^
    Back
    Association details:
    Biomarker:miR-381 underexpression
    Cancer:Breast Cancer
    Drug:doxorubicin hydrochloride (Topoisomerase II inhibitor)
    Direction:Resistant
    Evidence:
    Evidence Level:
    Resistant: D – Preclinical
    Source:
    Eur J Pharmacol
    Title:

    miR-381 induces sensitivity of breast cancer cells to doxorubicin by inactivation of MAPK signaling via FYN

    Published date:
    11/15/2018
    Excerpt:
    In this study, we found that miR-381 expression was down-regulated in DOX-resistant breast cancer cells.
    DOI:
    10.1016/j.ejphar.2018.09.024